Triplebar, a biotech startup, has raised a $20 million Series A round to expand its food and biopharmaceuticals portfolio.
Why it matters: The Emeryville, Calif.-based startup is part of an emerging group of companies developing environmentally low-impact ways to manufacture animal proteins bioidentical to those found in nature.
